AbbVie Inc.
ABBV · SEC filer number (CIK) 0001551152 · figures from FY2025
The last reported year
Revenue
$61.2B
+8.6% on the year before
Operating margin
24.6%
Net income
$4.2B
Return on invested capital
11.0%
Operating profit after tax
Read from this company's 10-K, filed 2026-02-20. See the filing on EDGAR
Six years
| Year | Revenue | Operating income | Net income |
|---|---|---|---|
| FY2025 | $61.2B | $15.1B | $4.2B |
| FY2024 | $56.3B | $9.1B | $4.3B |
| FY2023 | $54.3B | $12.8B | $4.9B |
| FY2022 | $58.1B | $18.1B | $11.8B |
| FY2021 | $56.2B | $17.9B | $11.5B |
| FY2020 | $45.8B | $11.4B | $4.6B |
Each year is shown as the company first reported it. 2 figures above were later republished by this company with a different number; the full research page shows both.
The rest of the research
Materiality reads ABBV's filings in full: every statement line with the concept it was tagged under, the ratios above across twenty years, cash flow, segment and dividend history, insider and institutional ownership, and a written analysis built only from the figures on the page.
Open the full research